A drug covered under Part D that does not meet the requirements of a rebatable drug specified in 428.101 for an applicable period will not be included in a reconciliation under this paragraph (d)
In these cases, we believe it is appropriate to provide relief to the MIPS eligible clinician so that they are not unfairly penalized for their third party intermediary's inaction
Pouches are similar in shape and size to a snus pouch, but theyre non-habit-forming and provide a safe and effective way to get the oral stimulation smokeless tobacco users to crave Alternative Tobacco - Non Tobacco dip alternative to dipping or chewing smokeless tobacco
one high-weighted improvement activity
That is, about 5 percent of ACOs participating in performance year 2023 were estimated to benefit from the proposed HEBA policy at rebasing (median effect about 1 percent increase to the benchmark), because an ACO would receive the proposed HEBA only if the HEBA adjustment were higher than the existing higher of adjustment method (see discussion in section III.G.7.b of this proposed rule, and proposed 425.652(a)(8)(ii)(B)( 1 ) and 425.662(c))
( Table 128 shows the impact on PFS payment for physicians' services based on the proposed policies included this proposed rule